Background: Magnetization transfer-prepared T1-weighted MRI can depict a hyperintense subregion of the substantia nigra involved in the degeneration process of Parkinson disease. Purpose: To evaluate quantitative measurement of substantia nigra volume by using MRI to support clinical diagnosis and staging of Parkinson disease. Materials and Methods: In this prospective study, a high-spatial-resolution magnetization transfer-prepared T1-weighted volumetric sequence was performed with a 3-T MRI machine between January 2014 and October 2015 for participants with de novo Parkinson disease, advanced Parkinson disease, and healthy control participants. A reproducible semiautomatic quantification analysis method that entailed mesencephalic intensity as an internal reference was used for hyperintense substantia nigra volumetry normalized to intracranial volume. A general linear model with age and sex as covariates was used to compare the three groups. Results: Eighty participants were evaluated: 20 healthy control participants (mean age 6 standard deviation, 56 years 6 11; 11 women), 29 participants with de novo Parkinson disease (64 years 6 10; 19 men), and 31 participants with advanced Parkinson disease (60 years 6 9; 16 women). Volumetric measurement of hyperintense substantia nigra from magnetization transfer-prepared T1-weighted MRI helped differentiate healthy control participants from participants with advanced Parkinson disease (mean difference for ipsilateral side, 64 mm3 6 14, P , .001; mean difference for contralateral side, 109 mm3 6 14, P , .001) and helped distinguish healthy control participants from participants with de novo Parkinson disease (mean difference for ipsilateral side, 45 mm3 6 15, P , .01; mean difference for contralateral side, 66 mm3 6 15, P , .001) and participants with de novo Parkinson disease from those with advanced Parkinson disease (mean difference for ipsilateral side, 20 mm3 6 13, P = .40; mean difference for contralateral side, 43 mm3 6 13, P = .004). Conclusion: Magnetization transfer-prepared T1-weighted MRI volumetry of the substantia nigra helped differentiate the stages of Parkinson disease.

Substantia Nigra Volumetry with 3-T MRI in de Novo and Advanced Parkinson Disease / Vitali, P.; Pan, M. I.; Palesi, F.; Germani, G.; Faggioli, A.; Anzalone, N.; Francaviglia, P.; Minafra, B.; Zangaglia, R.; Pacchetti, C.; Wheeler-Kingshott, C. A. M. G.. - In: RADIOLOGY. - ISSN 0033-8419. - 296:2(2020), pp. 401-410. [10.1148/radiol.2020191235]

Substantia Nigra Volumetry with 3-T MRI in de Novo and Advanced Parkinson Disease

Anzalone N.;
2020-01-01

Abstract

Background: Magnetization transfer-prepared T1-weighted MRI can depict a hyperintense subregion of the substantia nigra involved in the degeneration process of Parkinson disease. Purpose: To evaluate quantitative measurement of substantia nigra volume by using MRI to support clinical diagnosis and staging of Parkinson disease. Materials and Methods: In this prospective study, a high-spatial-resolution magnetization transfer-prepared T1-weighted volumetric sequence was performed with a 3-T MRI machine between January 2014 and October 2015 for participants with de novo Parkinson disease, advanced Parkinson disease, and healthy control participants. A reproducible semiautomatic quantification analysis method that entailed mesencephalic intensity as an internal reference was used for hyperintense substantia nigra volumetry normalized to intracranial volume. A general linear model with age and sex as covariates was used to compare the three groups. Results: Eighty participants were evaluated: 20 healthy control participants (mean age 6 standard deviation, 56 years 6 11; 11 women), 29 participants with de novo Parkinson disease (64 years 6 10; 19 men), and 31 participants with advanced Parkinson disease (60 years 6 9; 16 women). Volumetric measurement of hyperintense substantia nigra from magnetization transfer-prepared T1-weighted MRI helped differentiate healthy control participants from participants with advanced Parkinson disease (mean difference for ipsilateral side, 64 mm3 6 14, P , .001; mean difference for contralateral side, 109 mm3 6 14, P , .001) and helped distinguish healthy control participants from participants with de novo Parkinson disease (mean difference for ipsilateral side, 45 mm3 6 15, P , .01; mean difference for contralateral side, 66 mm3 6 15, P , .001) and participants with de novo Parkinson disease from those with advanced Parkinson disease (mean difference for ipsilateral side, 20 mm3 6 13, P = .40; mean difference for contralateral side, 43 mm3 6 13, P = .004). Conclusion: Magnetization transfer-prepared T1-weighted MRI volumetry of the substantia nigra helped differentiate the stages of Parkinson disease.
2020
Inglese
Radiological Society of North America Inc.
296
2
401
410
10
Pubblicato
Aged
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Parkinson Disease
Prospective Studies
Substantia Nigra
Substantia Nigra Volumetry with 3-T MRI in de Novo and Advanced Parkinson Disease / Vitali, P.; Pan, M. I.; Palesi, F.; Germani, G.; Faggioli, A.; Anzalone, N.; Francaviglia, P.; Minafra, B.; Zangaglia, R.; Pacchetti, C.; Wheeler-Kingshott, C. A. M. G.. - In: RADIOLOGY. - ISSN 0033-8419. - 296:2(2020), pp. 401-410. [10.1148/radiol.2020191235]
none
11
info:eu-repo/semantics/article
262
Vitali, P.; Pan, M. I.; Palesi, F.; Germani, G.; Faggioli, A.; Anzalone, N.; Francaviglia, P.; Minafra, B.; Zangaglia, R.; Pacchetti, C.; Wheeler-King...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/119037
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 20
social impact